Skip to main content
Erschienen in: Inflammation 3/2015

01.06.2015

Regulatory T Cells Contribute to the Recovery of Acute Lung Injury by Upregulating Tim-3

verfasst von: Haihan Song, Yujia Zhou, Guanggang Li, Jianwen Bai

Erschienen in: Inflammation | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Acute lung injury (ALI) is characterized by alveolar injury and uncontrolled inflammation. Mechanisms underlying pathogenesis of ALI are unknown. Regulatory T cells (Tregs), either natural or induced, suppress a variety of physiological and pathological immune responses. In the current study, we investigated whether Tregs were involved in the development of ALI. Proportion of CD4 + CD25 + FoxP3+ Tregs in the peripheral blood of 66 ALI patients and 30 healthy controls were examined by flow cytometry. Data showed that the percentage of Tregs in CD4+ T cells was significantly increased in patients than that in controls (10.8 versus 7.6 %, P = 0.003). Also, compared to those who died during the study, patients who survived presented significantly higher level of Tregs at the time of recruitment (P = 0.041). Since Tim-3 is a negative regulatory molecule and can modulate the function of Tregs, we evaluated Tim-3 level on Tregs and identified upregulation of the molecule in patients than that in controls. Moreover, compared to those who died during the study, patients who survived showed 1.7-fold higher level of Tim-3 on Tregs at the time of recruitment (P < 0.001). These results suggest that Tregs could affect the prognosis of ALI probably due to the upregulation of Tim-3.
Literatur
1.
Zurück zum Zitat Stephens, R.S., A.S. Shah, and G.J. Whitman. 2013. Lung injury and acute respiratory distress syndrome after cardiac surgery. The Annals of Thoracic Surgery 95: 1122–1129.CrossRefPubMed Stephens, R.S., A.S. Shah, and G.J. Whitman. 2013. Lung injury and acute respiratory distress syndrome after cardiac surgery. The Annals of Thoracic Surgery 95: 1122–1129.CrossRefPubMed
3.
Zurück zum Zitat Eves, N.D., N.D. Eves, Y. Song, A. Piper, and T.M. Maher. 2013. Year in review 2012: acute lung injury, interstitial lung diseases, sleep and physiology. Respirology (Carlton, Vic.) 18: 555–564.CrossRef Eves, N.D., N.D. Eves, Y. Song, A. Piper, and T.M. Maher. 2013. Year in review 2012: acute lung injury, interstitial lung diseases, sleep and physiology. Respirology (Carlton, Vic.) 18: 555–564.CrossRef
4.
Zurück zum Zitat D’Alessio, F.R., K. Tsushima, N.R. Aggarwal, E.E. West, M.H. Willett, M.F. Britos, M.R. Pipeling, R.G. Brower, R.M. Tuder, J.F. McDyer, and L.S. King. 2009. CD4 + CD25 + Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. The Journal of Clinical Investigation 119: 2898–2913.CrossRefPubMedCentralPubMed D’Alessio, F.R., K. Tsushima, N.R. Aggarwal, E.E. West, M.H. Willett, M.F. Britos, M.R. Pipeling, R.G. Brower, R.M. Tuder, J.F. McDyer, and L.S. King. 2009. CD4 + CD25 + Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. The Journal of Clinical Investigation 119: 2898–2913.CrossRefPubMedCentralPubMed
5.
Zurück zum Zitat Sakaguchi, S., K. Wing, and M. Miyara. 2007. Regulatory T cells - a brief history and perspective. European Journal of Immunology 37(Suppl 1): S116–123.CrossRefPubMed Sakaguchi, S., K. Wing, and M. Miyara. 2007. Regulatory T cells - a brief history and perspective. European Journal of Immunology 37(Suppl 1): S116–123.CrossRefPubMed
6.
Zurück zum Zitat Ni Choileain, N., M. MacConmara, Y. Zang, T.J. Murphy, J.A. Mannick, and J.A. Lederer. 2006. Enhanced regulatory T cell activity is an element of the host response to injury. Journal of Immunology (Baltimore, Md. : 1950) 176: 225–236.CrossRef Ni Choileain, N., M. MacConmara, Y. Zang, T.J. Murphy, J.A. Mannick, and J.A. Lederer. 2006. Enhanced regulatory T cell activity is an element of the host response to injury. Journal of Immunology (Baltimore, Md. : 1950) 176: 225–236.CrossRef
7.
Zurück zum Zitat D’Angelo, C., A. De Luca, T. Zelante, P. Bonifazi, S. Moretti, G. Giovannini, R.G. Iannitti, S. Zagarella, S. Bozza, S. Campo, G. Salvatori, and L. Romani. 2009. Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease. Journal of Immunology (Baltimore, Md. : 1950) 183: 4609–4618.CrossRef D’Angelo, C., A. De Luca, T. Zelante, P. Bonifazi, S. Moretti, G. Giovannini, R.G. Iannitti, S. Zagarella, S. Bozza, S. Campo, G. Salvatori, and L. Romani. 2009. Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease. Journal of Immunology (Baltimore, Md. : 1950) 183: 4609–4618.CrossRef
8.
Zurück zum Zitat Monney, L., C.A. Sabatos, J.L. Gaglia, A. Ryu, H. Waldner, T. Chernova, S. Manning, E.A. Greenfield, A.J. Coyle, R.A. Sobel, G.J. Freeman, and V.K. Kuchroo. 2002. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536–541.CrossRefPubMed Monney, L., C.A. Sabatos, J.L. Gaglia, A. Ryu, H. Waldner, T. Chernova, S. Manning, E.A. Greenfield, A.J. Coyle, R.A. Sobel, G.J. Freeman, and V.K. Kuchroo. 2002. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536–541.CrossRefPubMed
9.
Zurück zum Zitat Bai, J., X. Li, D. Tong, W. Shi, H. Song, and Q. Li. 2013. T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and prognosis of non-small-cell lung cancer. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 34: 805–809.CrossRef Bai, J., X. Li, D. Tong, W. Shi, H. Song, and Q. Li. 2013. T-cell immunoglobulin- and mucin-domain-containing molecule 3 gene polymorphisms and prognosis of non-small-cell lung cancer. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 34: 805–809.CrossRef
10.
Zurück zum Zitat Song, H., S. Ma, Z. Cha, L. Chen, D. Tong, L. Ma, W. Song, and J. Bai. 2013. T-cell immunoglobulin- and mucin-domain-containing molecule 3 genetic variants and HIV+ non-Hodgkin lymphomas. Inflammation 36: 793–799.CrossRefPubMed Song, H., S. Ma, Z. Cha, L. Chen, D. Tong, L. Ma, W. Song, and J. Bai. 2013. T-cell immunoglobulin- and mucin-domain-containing molecule 3 genetic variants and HIV+ non-Hodgkin lymphomas. Inflammation 36: 793–799.CrossRefPubMed
11.
Zurück zum Zitat Fernandez-Ponce, C., M. Dominguez-Villar, E. Aguado, and F. Garcia-Cozar. 2014. CD4+ primary T cells expressing HCV-core protein upregulate Foxp3 and IL-10, suppressing CD4 and CD8 T cells. PLoS One 9: e85191.CrossRefPubMedCentralPubMed Fernandez-Ponce, C., M. Dominguez-Villar, E. Aguado, and F. Garcia-Cozar. 2014. CD4+ primary T cells expressing HCV-core protein upregulate Foxp3 and IL-10, suppressing CD4 and CD8 T cells. PLoS One 9: e85191.CrossRefPubMedCentralPubMed
12.
Zurück zum Zitat Wang, J.P., Y. Zhang, X. Wei, J. Li, X.P. Nan, H.T. Yu, Y. Li, P.Z. Wang, and X.F. Bai. 2010. Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C. APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica 118: 261–270.CrossRefPubMed Wang, J.P., Y. Zhang, X. Wei, J. Li, X.P. Nan, H.T. Yu, Y. Li, P.Z. Wang, and X.F. Bai. 2010. Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C. APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica 118: 261–270.CrossRefPubMed
13.
Zurück zum Zitat Cai, L., Y. Fu, and Y. Zhang. 2014. APE1 Asp148Glu polymorphism and lung cancer susceptibility. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 35: 5237–5244.CrossRef Cai, L., Y. Fu, and Y. Zhang. 2014. APE1 Asp148Glu polymorphism and lung cancer susceptibility. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 35: 5237–5244.CrossRef
14.
Zurück zum Zitat Gu, X.Y., J. Wang, Y.Z. Luo, Q. Du, R.R. Li, H. Shi, and T.P. Yu. 2014. Down-regulation of miR-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting BAK1 in vitro. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 35: 5287–5293.CrossRef Gu, X.Y., J. Wang, Y.Z. Luo, Q. Du, R.R. Li, H. Shi, and T.P. Yu. 2014. Down-regulation of miR-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting BAK1 in vitro. Tumour Biology : The Journal of the International Society for Oncodevelopmental Biology and Medicine 35: 5287–5293.CrossRef
15.
Zurück zum Zitat Han, S., S. Feng, L. Xu, W. Shi, X. Wang, H. Wang, C. Yu, T. Dong, M. Xu, and G. Liang. 2014. Tim-3 on peripheral CD4(+) and CD8(+) T cells is involved in the development of glioma. DNA and Cell Biology 33: 245–250.CrossRefPubMed Han, S., S. Feng, L. Xu, W. Shi, X. Wang, H. Wang, C. Yu, T. Dong, M. Xu, and G. Liang. 2014. Tim-3 on peripheral CD4(+) and CD8(+) T cells is involved in the development of glioma. DNA and Cell Biology 33: 245–250.CrossRefPubMed
16.
Zurück zum Zitat Wu, J., C. Liu, S. Qian, and H. Hou. 2013. The expression of Tim-3 in peripheral blood of ovarian cancer. DNA and Cell Biology 32: 648–653.CrossRefPubMed Wu, J., C. Liu, S. Qian, and H. Hou. 2013. The expression of Tim-3 in peripheral blood of ovarian cancer. DNA and Cell Biology 32: 648–653.CrossRefPubMed
17.
Zurück zum Zitat Lee, J., E.J. Park, J.W. Noh, J.W. Hwang, E.K. Bae, J.K. Ahn, E.M. Koh, and H.S. Cha. 2012. Underexpression of TIM-3 and blunted galectin-9-induced apoptosis of CD4+ T cells in rheumatoid arthritis. Inflammation 35: 633–637.CrossRefPubMed Lee, J., E.J. Park, J.W. Noh, J.W. Hwang, E.K. Bae, J.K. Ahn, E.M. Koh, and H.S. Cha. 2012. Underexpression of TIM-3 and blunted galectin-9-induced apoptosis of CD4+ T cells in rheumatoid arthritis. Inflammation 35: 633–637.CrossRefPubMed
18.
Zurück zum Zitat Lu, X.X., K.S. McCoy, J.L. Xu, W.K. Hu, and H.B. Chen. 2013. Small interfering RNA targeting T-cell Ig mucin-3 decreases allergic airway inflammation and hyperresponsiveness. Inflammation 36: 582–591.CrossRefPubMed Lu, X.X., K.S. McCoy, J.L. Xu, W.K. Hu, and H.B. Chen. 2013. Small interfering RNA targeting T-cell Ig mucin-3 decreases allergic airway inflammation and hyperresponsiveness. Inflammation 36: 582–591.CrossRefPubMed
19.
Zurück zum Zitat Bhorade, S.M., H. Chen, L. Molinero, C. Liao, E.R. Garrity, W.T. Vigneswaran, R. Shilling, A. Sperling, A. Chong, and M.L. Alegre. 2010. Decreased percentage of CD4 + FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation 90: 540–546.CrossRefPubMed Bhorade, S.M., H. Chen, L. Molinero, C. Liao, E.R. Garrity, W.T. Vigneswaran, R. Shilling, A. Sperling, A. Chong, and M.L. Alegre. 2010. Decreased percentage of CD4 + FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation 90: 540–546.CrossRefPubMed
20.
Zurück zum Zitat Sun, J., Z.B. Han, W. Liao, S.G. Yang, Z. Yang, J. Yu, L. Meng, R. Wu, and Z.C. Han. 2011. Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4 + CD25+ Forkhead Boxp3 (FOXP3) + regulatory T cells and balancing anti- and pro-inflammatory factors. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 27: 587–596.CrossRef Sun, J., Z.B. Han, W. Liao, S.G. Yang, Z. Yang, J. Yu, L. Meng, R. Wu, and Z.C. Han. 2011. Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4 + CD25+ Forkhead Boxp3 (FOXP3) + regulatory T cells and balancing anti- and pro-inflammatory factors. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 27: 587–596.CrossRef
21.
Zurück zum Zitat Holm, T.L., J. Nielsen, and M.H. Claesson. 2004. CD4 + CD25+ regulatory T cells: I. Phenotype and physiology. APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica 112: 629–641.CrossRefPubMed Holm, T.L., J. Nielsen, and M.H. Claesson. 2004. CD4 + CD25+ regulatory T cells: I. Phenotype and physiology. APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica 112: 629–641.CrossRefPubMed
22.
Zurück zum Zitat Nielsen, J., T.L. Holm, and M.H. Claesson. 2004. CD4 + CD25+ regulatory T cells: II. Origin, disease models and clinical aspects. APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica 112: 642–650.CrossRefPubMed Nielsen, J., T.L. Holm, and M.H. Claesson. 2004. CD4 + CD25+ regulatory T cells: II. Origin, disease models and clinical aspects. APMIS : Acta Pathologica, Microbiologica, et Immunologica Scandinavica 112: 642–650.CrossRefPubMed
23.
Zurück zum Zitat Tang, L., J. Bai, C.S. Chung, J. Lomas-Neira, Y. Chen, X. Huang, and A. Ayala. 2014. Active players in resolution of shock/sepsis induced indirect lung injury: immunomodulatory effects of Tregs and PD-1. Journal of Leukocyte Biology 96: 809–20.CrossRefPubMed Tang, L., J. Bai, C.S. Chung, J. Lomas-Neira, Y. Chen, X. Huang, and A. Ayala. 2014. Active players in resolution of shock/sepsis induced indirect lung injury: immunomodulatory effects of Tregs and PD-1. Journal of Leukocyte Biology 96: 809–20.CrossRefPubMed
24.
Zurück zum Zitat Tang, L., L. Tang, J. Bai, C.S. Chung, J. Lomas-Neira, Y. Chen, X. Huang, and A. Ayala. 2014. PD-L1 regulates the Tregs’ capacity to repress shock/sepsis induced indirect lung injury (iALI) by recruiting phosphatase SHP-1. Shock (Augusta, Ga.). doi:10.1189/4MA1213-647RR. Tang, L., L. Tang, J. Bai, C.S. Chung, J. Lomas-Neira, Y. Chen, X. Huang, and A. Ayala. 2014. PD-L1 regulates the Tregs’ capacity to repress shock/sepsis induced indirect lung injury (iALI) by recruiting phosphatase SHP-1. Shock (Augusta, Ga.). doi:10.​1189/​4MA1213-647RR.
Metadaten
Titel
Regulatory T Cells Contribute to the Recovery of Acute Lung Injury by Upregulating Tim-3
verfasst von
Haihan Song
Yujia Zhou
Guanggang Li
Jianwen Bai
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 3/2015
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-0096-7

Weitere Artikel der Ausgabe 3/2015

Inflammation 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.